Keloid fibroblasts are more sensitive to Wnt3a treatment in terms of elevated cellular growth and fibronectin expression

Journal of Dermatological Science

Volumn 64, Issue 3, 2011, Pages 199-209

  Chua, Alvin Wen Choong ^a,b   Gan, Shu Uin ^b   Ting, Yixin ^a   Fu, Zhenying ^b   Lim, Che Kang ^a   Song, Colin ^a   Sabapathy, Kanaga ^c   Phan, Toan Thang ^b,d  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Cellular growth; Fibronectin; Keloid fibroblasts; SFRP1; Wnt

Indexed keywords

BETA CATENIN; FIBRONECTIN; MESSENGER RNA; QUERCETIN; SECRETED FRIZZLED RELATED PROTEIN 1; T CELL FACTOR PROTEIN; WNT3A PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; KELOID; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; WESTERN BLOTTING;

ADOLESCENT; ADULT; BETA CATENIN; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; FIBRONECTINS; GENE EXPRESSION REGULATION; GENES, REPORTER; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KELOID; MALE; MEMBRANE PROTEINS; PHENOTYPE; QUERCETIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TIME FACTORS; TRANSFECTION; WNT3A PROTEIN; YOUNG ADULT;

EID: 80055092525     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.09.008     Document Type: Article

References (50)

1. Bock O., Schmid-Ott G., Malewski P., Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006, 297:433-438.
2. Niessen F.B., Spauwen P.H., Schalkwijk J., Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999, 104:1435-1458.
3. Butler P.D., Longaker M.T., Yang G.P. Current progress in keloid research and treatment. J Am Coll Surg 2008, 206:731-741.
4. Chua A.W., Ma D., Gan S.U., Fu Z., Han H.C., Song C., et al. The role of R-Spondin2 in keratinocyte proliferation and epidermal thickening in keloid scarring. J Invest Dermatol 2010.
5. Sato M. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm Venereol 2006, 86:300-307.
6. Smith J.C., Boone B.E., Opalenik S.R., Williams S.M., Russell S.B. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 2008, 128:1298-1310.
7. Russell S.B., Russell J.D., Trupin K.M., Gayden A.E., Opalenik S.R., Nanney L.B., et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 2010, 130:2489-2496.
8. Gumz M.L., Zou H., Kreinest P.A., Childs A.C., Belmonte L.S., LeGrand S.N., et al. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin Cancer Res 2007, 13:4740-4749.
9. Calderon M., Lawrence W.T., Banes A.J. Increased proliferation in keloid fibroblasts wounded in vitro. J Surg Res 1996, 61:343-347.
10. Lim C.P., Phan T.T., Lim I.J., Cao X. Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration. Oncogene 2006, 25:5416-5425.
11. Fujiwara M., Muragaki Y., Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol 2005, 153:295-300.
12. Tuan T.L., Nichter L.S. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998, 4:19-24.
13. Yun M.S., Kim S.E., Jeon S.H., Lee J.S., Choi K.Y. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J Cell Sci 2005, 118:313-322.
14. Chen S., McLean S., Carter D.E., Leask A. The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts. J Cell Commun Signal 2007, 1:175-183.
15. Kim S.E., Choi K.Y. EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation. Cell Signal 2007, 19:1554-1564.
16. Neth P., Ciccarella M., Egea V., Hoelters J., Jochum M., Ries C. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells 2006, 24:1892-1903.
17. Lam A.P., Flozak A.S., Russell S., Wei J., Jain M., Mutlu G.M., et al. Nuclear {beta}-catenin is increased in SSc pulmonary fibrosis and promotes lung fibroblast migration and proliferation. Am J Respir Cell Mol Biol 2011.
18. Konigshoff M., Balsara N., Pfaff E.M., Kramer M., Chrobak I., Seeger W., et al. Functional Wnt signaling is increased in idiopathic pulmonary fibrosis. PLoS One 2008, 3:e2142.
19. Babu M., Diegelmann R., Oliver N. Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol Cell Biol 1989, 9:1642-1650.
20. Kischer C.W., Hendrix M.J. Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res 1983, 231:29-37.
21. Park C.H., Chang J.Y., Hahm E.R., Park S., Kim H.K., Yang C.H. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 2005, 328:227-234.
22. Kawahara T., Kawaguchi-Ihara N., Okuhashi Y., Itoh M., Nara N., Tohda S. Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res 2009, 2(9):4629-4632.
23. Phan T.T., See P., Tran E., Nguyen T.T., Chan S.Y., Lee S.T., et al. Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids. Br J Dermatol 2003, 148:544-552.
24. Phan T.T., Lim I.J., Chan S.Y., Tan E.K., Lee S.T., Longaker M.T. Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars. J Trauma 2004, 57:1032-1037.
25. Mustoe T.A., Cooter R.D., Gold M.H., Hobbs F.D., Ramelet A.A., Shakespeare P.G., et al. International clinical recommendations on scar management. Plast Reconstr Surg 2002, 110:560-571.
26. Ueda Y., Hijikata M., Takagi S., Takada R., Takada S., Chiba T., et al. Wnt/beta-catenin signaling suppresses apoptosis in low serum medium and induces morphologic change in rodent fibroblasts. Int J Cancer 2002, 99:681-688.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
28. Uzawa K., Marshall M.K., Katz E.P., Tanzawa H., Yeowell H.N., Yamauchi M. Altered posttranslational modifications of collagen in keloid. Biochem Biophys Res Commun 1998, 249:652-655.
29. Uitto J., Perejda A.J., Abergel R.P., Chu M.L., Ramirez F. Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci U S A 1985, 82:5935-5939.
30. Kauh Y.C., Rouda S., Mondragon G., Tokarek R., diLeonardo M., Tuan R.S., et al. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 1997, 37:586-589.
31. Xia W., Kong W., Wang Z., Phan T.T., Lim I.J., Longaker M.T., et al. Increased CCN2 transcription in keloid fibroblasts requires cooperativity between AP-1 and SMAD binding sites. Ann Surg 2007, 246:886-895.
32. Igarashi A., Nashiro K., Kikuchi K., Sato S., Ihn H., Fujimoto M., et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996, 106:729-733.
33. Torii K., Nishizawa K., Kawasaki A., Yamashita Y., Katada M., Ito M., et al. Anti-apoptotic action of Wnt5a in dermal fibroblasts is mediated by the PKA signaling pathways. Cell Signal 2008, 20:1256-1266.
34. Baksh D., Tuan R.S. Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol 2007, 212:817-826.
35. Bowley E., O'Gorman D.B., Gan B.S. Beta-catenin signaling in fibroproliferative disease. J Surg Res 2007, 138:141-150.
36. Cheon S., Poon R., Yu C., Khoury M., Shenker R., Fish J., et al. Prolonged beta-catenin stabilization and tcf-dependent transcriptional activation in hyperplastic cutaneous wounds. Lab Invest 2005, 85:416-425.
37. Kawano Y., Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003, 116:2627-2634.
38. He W., Zhang L., Ni A., Zhang Z., Mirotsou M., Mao L., et al. Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction. Proc Natl Acad Sci U S A 2010, 107:21110-21115.
39. Kaplan F.S., Pignolo R.J., Shore E.M. The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine Growth Factor Rev 2009, 20:399-407.
40. Esteve P., Bovolenta P. The advantages and disadvantages of sfrp1 and sfrp2 expression in pathological events. Tohoku J Exp Med 2010, 221:11-17.
41. Shang Y.C., Wang S.H., Xiong F., Zhao C.P., Peng F.N., Feng S.W., et al. Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells. Acta Pharmacol Sin 2007, 28:1761-1774.
42. Gradl D., Kuhl M., Wedlich D. The Wnt/Wg signal transducer beta-catenin controls fibronectin expression. Mol Cell Biol 1999, 19:5576-5587.
43. Howard J.C., Varallo V.M., Ross D.C., Roth J.H., Faber K.J., Alman B., et al. Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro. BMC Musculoskelet Disord 2003, 4:16.
44. Karow M., Popp T., Egea V., Ries C., Jochum M., Neth P. Wnt signalling in mouse mesenchymal stem cells: impact on proliferation, invasion and MMP expression. J Cell Mol Med 2009, 13:2506-2520.
45. Takahashi M., Tsunoda T., Seiki M., Nakamura Y., Furukawa Y. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Oncogene 2002, 21:5861-5867.
46. Hlubek F., Spaderna S., Jung A., Kirchner T., Brabletz T. Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas. Int J Cancer 2004, 108:321-326.
47. Wu B., Crampton S.P., Hughes C.C. Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 2007, 26:227-239.
48. Arce L., Yokoyama N.N., Waterman M.L. Diversity of LEF/TCF action in development and disease. Oncogene 2006, 25:7492-7504.
49. Imaizumi R., Akasaka Y., Inomata N., Okada E., Ito K., Ishikawa Y., et al. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression. Histopathology 2009, 54:722-730.
50. Kerr D.J., La Thangue N.B. Signal transduction blockade and cancer: combination therapy or multi-targeted inhibitors?. Ann Oncol 2004, 15:1727-1729.